Abstract: Provided is a microphone capable of reducing a plane area seen from above, and further increasing a capacity of a back chamber of an acoustic sensor. An interposer 52 is mounted on a top surface of a circuit board 43, and an acoustic sensor 51 is mounted on the top surface thereof. A signal processing circuit 53 is accommodated in a space 70 provided in the interposer 52, and mounted on the circuit board 43. The acoustic sensor 51 is connected to the circuit board 43 through a wiring structure provided in the interposer 52. The acoustic sensor 51, the interposer 52 and the like are covered by a cover 42 put on the top surface of the circuit board 43. In the cover 42, a sound introduction hole 48 is opened in a position opposed to the front chamber of the acoustic sensor 51. The interposer 52 is formed with a ventilation notch 71 for acoustically communicating a space below a diaphragm 56 of the acoustic sensor 51 with a space inside the cover 42 and outside the interposer 52.

Abstract: Hydraulic fluid is supplied from a hydraulic fluid supply opening to a hydraulic fluid supply portion. The hydraulic fluid in the hydraulic fluid supply portion is supplied to a primary hydraulic fluid storage chamber and to a secondary hydraulic fluid storage chamber via a hydraulic fluid supply passage. An oblong cylinder-shaped portion that has a chamber is formed between the hydraulic fluid supply opening and the hydraulic fluid supply portion. Further, a volume-augmented chamber forming portion that has a volume-augmented chamber that is communicated with the chamber is disposed in this oblong cylinder-shaped portion. In that case, at least part of the volume-augmented chamber is positioned above a MAX line of the hydraulic fluid.

Abstract: The present invention provides a method for producing a carotenoid-containing composition, comprising the steps of: subjecting a culture of a carotenoid-producing microorganism to an extraction treatment using a water-soluble organic solvent; dispersing the resulting extract solution in water for micellization; heat stirring the resulting micellized solution in a solvent break the micelles and precipitate the carotenoid component of interest to obtain the precipitate; collecting and heat washing the precipitate with ethanol; and further subjecting the precipitate to pulverization/drying; and food, a pharmaceutical composition and a cosmetic product comprising the carotenoid-containing composition.

Abstract: An optical filter comprising at least one dye compound (i), at least one layered clay mineral (ii), and thermoplastic substance (iii) if needed. The optical filter of the present invention is excellent in light resistance and moist heat resistance and suitable for improving the image quality and preventing glare due to external light in image display devices.

Abstract: A material pressure feeding apparatus 10 includes a container 12 for receiving a bag 11, in which a viscous material M is contained, a press member 13 exerting a pressing force on the material, a pressure feeder 15 pressure-feeding, to the outside, the material M sucked by the pressing force by the press member 13, and an annular member 16 positioned on the outer peripheral side of the press member 13. The press member 13 has a supporting space S on the outer peripheral side thereof, and a ring portion 40 constituting an annular member 16 is supported in the supporting space S in a relatively movable state. Thus, even when the press member 13 is inclined, the annular member 16 is configured so as not to form a clearance between it and the inner peripheral surface of the container 12 without any influence of the inclination.

Abstract: [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R1 represents C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 represents aryl or heteroaryl; R3 represents a hydrogen atom, C1-6 alkyl, or the like; and M1, M2, M3, and M4 independently represent a hydrogen atom, C1-6 alkyl, or the like, or M1, together with M2, M3, or M4, forms —CH2— or the like.

Abstract: An image processing device includes a multiplier 1 for multiplying a pixel signal P(x) by a weighting factor ?0 (0??0?1), a delay element 2 for delaying the pixel signal P(x) which has not been multiplied yet by the weighting factor ?0 by the multiplier 1 by one pixel, and a multiplier 3 for multiplying the pixel signal P(x?1) delayed by the delay element 2 by a weighting factor ?1 (0??1?1), the total sum of the weighting factors ?0 and ?1 being larger than 1 and smaller than an upper limit ?max. An adder 4 adds the multiplication result ?0·P(x) of the multiplier 1 and the multiplication result ?1·P(x?1) of the multiplier 3, and a limiter 5 limits the addition result P?(x) of the adder 4 in such a way that P?(x) falls within a maximum density value Pmax.

Abstract: [Problem] To provide an inexpensive reservoir tank in which a light-out fluid level can be moved even farther away from a lead switch while reliably moving a float up and down and stabilizing the operation of the lead switch. [Solution] A fluid volume detection unit 19 of a reservoir tank 5 has a float 23 on which a magnet 22 that switches a lead switch 24 on and off is disposed and which moves up and down in accordance with the fluid level of hydraulic fluid. The lead switch 24 is disposed above the magnet 23. The float 23 has a float body 23a, magnet braces 23b and 23c on an upper end of the float body 23a, a magnet support portion 23d that supports the magnet 22 on upper ends of the magnet braces 23b and 23c, and reinforcement ribs 23b1 and 23b2 and 23c1 and 23c2. Because of this, the magnet 22 stably moves up and down, and the operation of the lead switch 24 is stable.

Abstract: An RFID module including an antenna element forming an RFID antenna; an RFID circuit block to which the antenna element is connected; and a first resonance frequency adjustment circuit having an element that includes a drain terminal connected to the antenna element, a gate terminal that is grounded, and a source terminal that is grounded, wherein a pull-up resistor is connected between the drain terminal and a power supply.

Abstract: [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R1 represents C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 represents aryl or heteroaryl; R3 represents a hydrogen atom, C1-6 alkyl, or the like; and M1, M2, M3, and M4 independently represent a hydrogen atom, C1-6 alkyl, or the like, or M1, together with M2, M3, or M4, forms —CH2— or the like.

Abstract: A non-contact wireless communication apparatus and a mobile terminal apparatus are provided.

Abstract: Disclosed is a reservoir tank, comprising a connector body installed on a master cylinder, a hose connection tube body, which is arranged protruding from the edge of the connector body and has a hose connected with the reservoir tank connected thereto, and a conveying arm guide section as an interference preventing section, which is arranged on the connector body and prevents interference with the conveying jig when the connector body is supported by a conveying jig. When a conveying arm of the conveying jig abuts the conveying arm guide section and supports the connector body, the conveying arm will not interfere with the hose connection tube body due to the conveying arm guide section.

Abstract: Provided is a master cylinder hydraulic fluid flow control valve which can effectively decrease a pressure receiving area of a floating valve element when the floating valve element is seated on a valve seat, can favorably maintain a sealing function of a sealing member, and can suppress the increase of the number of assembling operation man-hours. A floating valve element 26a is vertically movably accommodated in a master cylinder connecting nipple portion 6b2, 6c2 which is hermetically mounted on a tandem master cylinder 4 by sealing members 23, 24 and forms a fluid passage between a reservoir tank and a tandem master cylinder 4 therein, and a valve seat 26b on which the floating valve element 26a is seatable is arranged in the master cylinder connecting nipple portion 6b2, 6c2.

Abstract: [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R1 represents C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 represents aryl or heteroaryl; R3 represents a hydrogen atom, C1-6 alkyl, or the like; and M1, M2, M3, and M4 independently represent a hydrogen atom, C1-6 alkyl, or the like, or M1, together with M2, M3, or M4, forms —CH2— or the like.

Abstract: Disclosed is a compound represented by the formula (I) below and a pharmaceutically acceptable salt thereof. This compound is useful for treatment of obesity, diabetes and the like. [In the formula (I), Ar represents a benzene ring or the like; X1 represents a nitrogen atom, a sulfur atom or the like; R1 represents an aryl group or the like; X2 represents a group represented by the following formula (II): (wherein R4 and R5 respectively represent a lower alkyl group or the like, and m represents a number of 2-4) or the like; one of X and Y represents an oxygen atom and the other represents a sulfanyl group or the like; and X3-X6 respectively represent —CH—, a nitrogen atom or the like.

Abstract: [PROBLEMS] To provide compounds useful as preventives or remedies for circulatory diseases, nervous diseases, metabolic diseases, reproductive system diseases, and digestive diseases. [MEANS FOR SOLVING PROBLEMS] Compounds represented by the general formula (I) or pharmaceutically acceptable salts thereof: wherein R1 is C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 is phenyl, heteroaryl, or the like; Q is N or CH; and M1, M2, M3 and M4 are each independently hydrogen or C1-6 alkyl, or alternatively M1 together with M2 or M3 forms —CH2-CH2- or the like, or M4 together with M2 or M3 forms —CH2-CH2- or the like, with the proviso that M1, M2, M3, and M4 are such that one —CH2- or —CH2-CH2- group is formed thereamong.

Abstract: A brass instrument practice device (1) is used for practicing while holding a lip state for playing a brass instrument and has a tubular body (10) and a mouth piece portion (20). The tubular body (10) has a through hole (11) formed inside. The mouth piece portion (20) is secured on one end side of the tubular body (10), has a cross-sectional shape relatively long in one direction so as to fit the shape between the upper and lower lips, and has an opening portion (22) communicating with the through hole (11) and constituting a flow path through which air from the lips flows.

Abstract: [Problem] To provide a compound that is useful as an agent in the prevention and treatment of circulatory system, nervous system, metabolic, reproductive system, and gastrointestinal diseases. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I): [wherein, Z represents formula (II-1), (II-2), or (II-3), wherein m and n are 0, 1, or 2, Y represents CR3 or N, R1 represents a C1-6 alkyl, C3-8 cycloalkyl, etc., R2 represents phenyl or a heteroaryl, etc., R3 and R4 each independently represent a hydrogen atom, a C1-6 alkyl, etc., M1, M2, M3, and M4 each independently represent a hydrogen atom, a C1-6 alkyl, etc.

Abstract: 2-Aryl imidazoline derivatives are provided that are useful as anti-obesity agents or the like. A compound represented by Formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 and R2 each independently represent a hydrogen atom, halogen, C1-6alkyl, or the like; R3a, R3b, R4a and R4b each independently represent a hydrogen atom, C1-6alkyl, or haloC1-6alkyl; and Ar represents aryl, wherein the aryl may be substituted with 1 to 3 substituents such as halogen, cyano, C1-6alkyl, haloC1-6alkyl, C1-6alkyloxy, haloC1-6alkyloxy, hydroxy, amino, monoC1-6alkylamino, diC1-6alkylamino, and C1-6alkyloxy-carbonyl.

Abstract: A compound represented by the general formula (I-a): [wherein R1a and R2a each means hydrogen, lower cycloalkyl, lower alkyl, etc.; R3a means hydrogen, lower cycloalkyl, lower alkyl, etc.; R4a and R5a each means lower alkyl, lower cycloalkyl, etc. or R4a and R5a are bonded to each other to form lower cycloalkylidene; and R6a means lower alkyl, lower haloalkyl, etc.]. This compound functions as an LCE inhibitor and is useful as a therapeutic agent for various circulatory diseases, nervous diseases, metabolic diseases, reproductive diseases, digestive tract diseases, neoplasm, infectious diseases, etc.